Randomisierte kontrollierte Studie
Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.9517 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Seemal R Desai und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hyperpigmentation, Resorcinols, Facial Dermatoses.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
HyperpigmentationResorcinolsFacial DermatosesHumansFemaleMaleMiddle AgedAdultTreatment OutcomeFaceSkin PigmentationAgedSkin CreamAdministration, CutaneousYoung Adult
Substanzen
Resorcinols
Zitieren
APA
Desai, S. R., Lain, E. T., Elbuluk, N., & Frey, C. (2025). Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9517
Vancouver
Desai SR, Lain ET, Elbuluk N, Frey C. Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9517
BibTeX
@article{Desai2025,
author = {Desai, Seemal R and Lain, Edward Ted and Elbuluk, Nada and Frey, Cheri},
title = {Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.9517}
}
EUVIMED